APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma-Aminobutyric Acid (GABA) Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gamma-Aminobutyric Acid (GABA) Supplement Market Outlook and Growth Opportunities 2026

31 December 2025195 pages

Choose your research edition.

Industry ResearchGamma-Aminobutyric Acid (GABA) Supplement Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma-Aminobutyric Acid (GABA) Supplement Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gamma-Aminobutyric Acid (GABA) Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma-Aminobutyric Acid (GABA) Supplement Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma-Aminobutyric Acid (GABA) Supplement Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Gamma-Aminobutyric Acid (GABA) Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gamma-Aminobutyric Acid (GABA) Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gamma-Aminobutyric Acid (GABA) Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gamma-Aminobutyric Acid (GABA) Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gamma-Aminobutyric Acid (GABA) Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gamma-Aminobutyric Acid (GABA) Supplement market include Amazing Nutrition, Country Life, Horbaach, Integrative Therapeutics, Nature's Truth, Now Foods, Nusa Pure, Nutrabio and Nutrabulk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gamma-Aminobutyric Acid (GABA) Supplement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gamma-Aminobutyric Acid (GABA) Supplement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gamma-Aminobutyric Acid (GABA) Supplement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gamma-Aminobutyric Acid (GABA) Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

Gamma-Aminobutyric Acid (GABA) Supplement Segment by Company

Amazing Nutrition

Country Life

Horbaach

Integrative Therapeutics

Nature's Truth

Now Foods

Nusa Pure

Nutrabio

Nutrabulk

Pure Encapsulations

Solgar

Thorne

Vitanica

Gamma-Aminobutyric Acid (GABA) Supplement Segment by Type

Capsules

Powder

Gamma-Aminobutyric Acid (GABA) Supplement Segment by Application

Retailer

Online Shopping

Others

Gamma-Aminobutyric Acid (GABA) Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gamma-Aminobutyric Acid (GABA) Supplement status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gamma-Aminobutyric Acid (GABA) Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gamma-Aminobutyric Acid (GABA) Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze Gamma-Aminobutyric Acid (GABA) Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid (GABA) Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid (GABA) Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid (GABA) Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gamma-Aminobutyric Acid (GABA) Supplement market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma-Aminobutyric Acid (GABA) Supplement industry.

Chapter 3: Detailed analysis of Gamma-Aminobutyric Acid (GABA) Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gamma-Aminobutyric Acid (GABA) Supplement Industry Trends Table 2. Gamma-Aminobutyric Acid (GABA) Supplement Industry Drivers Table 3. Gamma-Aminobutyric Acid (GABA) Supplement Industry Opportunities and Challenges Table 4. Gamma-Aminobutyric Acid (GABA) Supplement Industry Restraints Table 5. Global Gamma-Aminobutyric Acid (GABA) Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gamma-Aminobutyric Acid (GABA) Supplement Revenue Share by Company (2021-2026) Table 7. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Company (2021-2026) Table 9. Global Gamma-Aminobutyric Acid (GABA) Supplement Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gamma-Aminobutyric Acid (GABA) Supplement Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gamma-Aminobutyric Acid (GABA) Supplement Key Company Manufacturing Base & Headquarters Table 12. Global Gamma-Aminobutyric Acid (GABA) Supplement Company, Product Type & Application Table 13. Global Gamma-Aminobutyric Acid (GABA) Supplement Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gamma-Aminobutyric Acid (GABA) Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules Table 18. Significant Companies of Powder Table 19. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Type (2021-2026) Table 23. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Type (2027-2032) Table 24. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type (2021-2026) Table 28. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retailer Table 30. Significant Companies of Online Shopping Table 31. Significant Companies of Others Table 32. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Application (2021-2026) Table 36. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Application (2027-2032) Table 37. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application (2021-2026) Table 41. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application (2027-2032) Table 42. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2021-2026) & (K Units) Table 44. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Market Share by Region (2021-2026) Table 45. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2027-2032) & (K Units) Table 46. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Market Share by Region (2027-2032) Table 47. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Region (2021-2026) Table 50. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Region (2027-2032) Table 52. Global Gamma-Aminobutyric Acid (GABA) Supplement Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Gamma-Aminobutyric Acid (GABA) Supplement Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2021-2026) & (K Units) Table 57. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Market Share by Country (2021-2026) Table 58. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2027-2032) & (K Units) Table 59. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Market Share by Country (2027-2032) Table 60. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Market Share by Country (2021-2026) Table 62. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Market Share by Country (2027-2032) Table 64. Amazing Nutrition Company Information Table 65. Amazing Nutrition Business Overview Table 66. Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 68. Amazing Nutrition Recent Development Table 69. Country Life Company Information Table 70. Country Life Business Overview Table 71. Country Life Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Country Life Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 73. Country Life Recent Development Table 74. Horbaach Company Information Table 75. Horbaach Business Overview Table 76. Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 78. Horbaach Recent Development Table 79. Integrative Therapeutics Company Information Table 80. Integrative Therapeutics Business Overview Table 81. Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 83. Integrative Therapeutics Recent Development Table 84. Nature's Truth Company Information Table 85. Nature's Truth Business Overview Table 86. Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 88. Nature's Truth Recent Development Table 89. Now Foods Company Information Table 90. Now Foods Business Overview Table 91. Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 93. Now Foods Recent Development Table 94. Nusa Pure Company Information Table 95. Nusa Pure Business Overview Table 96. Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 98. Nusa Pure Recent Development Table 99. Nutrabio Company Information Table 100. Nutrabio Business Overview Table 101. Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 103. Nutrabio Recent Development Table 104. Nutrabulk Company Information Table 105. Nutrabulk Business Overview Table 106. Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 108. Nutrabulk Recent Development Table 109. Pure Encapsulations Company Information Table 110. Pure Encapsulations Business Overview Table 111. Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 113. Pure Encapsulations Recent Development Table 114. Solgar Company Information Table 115. Solgar Business Overview Table 116. Solgar Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Solgar Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 118. Solgar Recent Development Table 119. Thorne Company Information Table 120. Thorne Business Overview Table 121. Thorne Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Thorne Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 123. Thorne Recent Development Table 124. Vitanica Company Information Table 125. Vitanica Business Overview Table 126. Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio Table 128. Vitanica Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Gamma-Aminobutyric Acid (GABA) Supplement Distributors List Table 132. Gamma-Aminobutyric Acid (GABA) Supplement Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Gamma-Aminobutyric Acid (GABA) Supplement Product Image Figure 2. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales (2021-2032) & (K Units) Figure 5. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gamma-Aminobutyric Acid (GABA) Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules Image Figure 10. Powder Image Figure 11. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Type (2021-2032) Figure 14. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type (2021-2032) Figure 17. Retailer Image Figure 18. Online Shopping Image Figure 19. Others Image Figure 20. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Application (2021-2032) Figure 23. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application (2021-2032) Figure 26. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 31. North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 37. South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Gamma-Aminobutyric Acid (GABA) Supplement Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Gamma-Aminobutyric Acid (GABA) Supplement Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Powder
Applications
  • Retailer
  • Online Shopping
  • Others
Companies covered
  • Amazing Nutrition
  • Country Life
  • Horbaach
  • Integrative Therapeutics
  • Nature's Truth
  • Now Foods
  • Nusa Pure
  • Nutrabio
  • Nutrabulk
  • Pure Encapsulations
  • Solgar
  • Thorne
  • Vitanica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  4. 1.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume (2021-2032)
  5. 1.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gamma-Aminobutyric Acid (GABA) Supplement Market Dynamics
  1. 2.1 Gamma-Aminobutyric Acid (GABA) Supplement Industry Trends
  2. 2.2 Gamma-Aminobutyric Acid (GABA) Supplement Industry Drivers
  3. 2.3 Gamma-Aminobutyric Acid (GABA) Supplement Industry Opportunities and Challenges
  4. 2.4 Gamma-Aminobutyric Acid (GABA) Supplement Industry Restraints
3 Gamma-Aminobutyric Acid (GABA) Supplement Market by Company
  1. 3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Revenue Ranking in 2025
  2. 3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Revenue by Company (2021-2026)
  3. 3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Company (2021-2026)
  4. 3.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Average Price by Company (2021-2026)
  5. 3.5 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Ranking (2024-2026)
  6. 3.6 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Manufacturing Base and Headquarters
  7. 3.7 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Product Type and Application
  8. 3.8 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gamma-Aminobutyric Acid (GABA) Supplement Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gamma-Aminobutyric Acid (GABA) Supplement Market by Type
  1. 4.1 Gamma-Aminobutyric Acid (GABA) Supplement Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Powder
  4. 4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type
  5. 4.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type
  9. 4.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type (2021-2032)
5 Gamma-Aminobutyric Acid (GABA) Supplement Market by Application
  1. 5.1 Gamma-Aminobutyric Acid (GABA) Supplement Application Introduction
  2. 5.1.1 Retailer
  3. 5.1.2 Online Shopping
  4. 5.1.3 Others
  5. 5.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application
  6. 5.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application
  10. 5.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application (2021-2032)
6 Gamma-Aminobutyric Acid (GABA) Supplement Regional Sales and Value Analysis
  1. 6.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2021-2032)
  3. 6.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2021-2026
  4. 6.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2027-2032)
  5. 6.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2027-2032)
  9. 6.5 Global Gamma-Aminobutyric Acid (GABA) Supplement Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  12. 6.6.2 North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  15. 6.7.2 Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  21. 6.9.2 South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2025 VS 2032
7 Gamma-Aminobutyric Acid (GABA) Supplement Country-level Sales and Value Analysis
  1. 7.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2021-2032)
  4. 7.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2021-2026)
  5. 7.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2027-2032)
  6. 7.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amazing Nutrition
  2. 8.1.1 Amazing Nutrition Company Information
  3. 8.1.2 Amazing Nutrition Business Overview
  4. 8.1.3 Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  6. 8.1.5 Amazing Nutrition Recent Developments
  7. 8.2 Country Life
  8. 8.2.1 Country Life Company Information
  9. 8.2.2 Country Life Business Overview
  10. 8.2.3 Country Life Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Country Life Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  12. 8.2.5 Country Life Recent Developments
  13. 8.3 Horbaach
  14. 8.3.1 Horbaach Company Information
  15. 8.3.2 Horbaach Business Overview
  16. 8.3.3 Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  18. 8.3.5 Horbaach Recent Developments
  19. 8.4 Integrative Therapeutics
  20. 8.4.1 Integrative Therapeutics Company Information
  21. 8.4.2 Integrative Therapeutics Business Overview
  22. 8.4.3 Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  24. 8.4.5 Integrative Therapeutics Recent Developments
  25. 8.5 Nature's Truth
  26. 8.5.1 Nature's Truth Company Information
  27. 8.5.2 Nature's Truth Business Overview
  28. 8.5.3 Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  30. 8.5.5 Nature's Truth Recent Developments
  31. 8.6 Now Foods
  32. 8.6.1 Now Foods Company Information
  33. 8.6.2 Now Foods Business Overview
  34. 8.6.3 Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  36. 8.6.5 Now Foods Recent Developments
  37. 8.7 Nusa Pure
  38. 8.7.1 Nusa Pure Company Information
  39. 8.7.2 Nusa Pure Business Overview
  40. 8.7.3 Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  42. 8.7.5 Nusa Pure Recent Developments
  43. 8.8 Nutrabio
  44. 8.8.1 Nutrabio Company Information
  45. 8.8.2 Nutrabio Business Overview
  46. 8.8.3 Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  48. 8.8.5 Nutrabio Recent Developments
  49. 8.9 Nutrabulk
  50. 8.9.1 Nutrabulk Company Information
  51. 8.9.2 Nutrabulk Business Overview
  52. 8.9.3 Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  54. 8.9.5 Nutrabulk Recent Developments
  55. 8.10 Pure Encapsulations
  56. 8.10.1 Pure Encapsulations Company Information
  57. 8.10.2 Pure Encapsulations Business Overview
  58. 8.10.3 Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  60. 8.10.5 Pure Encapsulations Recent Developments
  61. 8.11 Solgar
  62. 8.11.1 Solgar Company Information
  63. 8.11.2 Solgar Business Overview
  64. 8.11.3 Solgar Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Solgar Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  66. 8.11.5 Solgar Recent Developments
  67. 8.12 Thorne
  68. 8.12.1 Thorne Company Information
  69. 8.12.2 Thorne Business Overview
  70. 8.12.3 Thorne Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Thorne Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  72. 8.12.5 Thorne Recent Developments
  73. 8.13 Vitanica
  74. 8.13.1 Vitanica Company Information
  75. 8.13.2 Vitanica Business Overview
  76. 8.13.3 Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
  78. 8.13.5 Vitanica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gamma-Aminobutyric Acid (GABA) Supplement Value Chain Analysis
  2. 9.1.1 Gamma-Aminobutyric Acid (GABA) Supplement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gamma-Aminobutyric Acid (GABA) Supplement Sales Mode & Process
  6. 9.2 Gamma-Aminobutyric Acid (GABA) Supplement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gamma-Aminobutyric Acid (GABA) Supplement Distributors
  9. 9.2.3 Gamma-Aminobutyric Acid (GABA) Supplement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst